NYLIM
ALKS icon

New York Life Investment Management’s Alkermes ALKS Stock Holding History

New York Life Investment Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,315
Closed -$360K – 870
2024
Q1 		$360K Buy
13,315
+970
+8% +$27.5K ﹤0.01% 1205
2023
Q4 		$342K Sell
12,345
-285
-2% -$7.4K ﹤0.01% 1134
2023
Q3 		$354K Sell
12,630
-2,003
-14% -$58.7K ﹤0.01% 998
2023
Q2 		$458K Sell
14,633
-2,287
-14% -$69.2K ﹤0.01% 793
2023
Q1 		$477K Buy
+16,920
New +$461K 0.01% 970

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York Life Investment Management's ALKS Position: Q2 2024 in Review

New York Life Investment Management sold out of Alkermes (ALKS) in Q2 2024, closing a stake of 13,315 shares — an estimated $360K sold.

New York Life Investment Management first reported a position in ALKS in Q1 2023 and held it in 5 quarters. The position peaked at $477K in Q1 2023. 322 funds tracked by Wall St. Rank hold ALKS as of Q2 2024.

  • New York Life Investment Management reported no remaining Alkermes position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 13,315 Alkermes shares in Q2 2024, an estimated $360K.
  • New York Life Investment Management first reported a position in Alkermes in Q1 2023 and held it in 5 quarters.
  • New York Life Investment Management's Alkermes position peaked at $477K in Q1 2023.
  • 322 funds tracked by Wall St. Rank held Alkermes as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.